Here, the protective effects of CD8+ T cell in preventing tumor recurrence were shown in both the younger and the older COAD patients, consistent with its favorable prognostic effects in colorectal cancer in previous studies 114-116, indicating its anti-tumor property during COAD progression and this would provide a basis for its application in COAD immunotherapy. The gene discussed is CD8A; the disease is colon adenocarcinoma.